<DOC>
	<DOCNO>NCT01663038</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetics fixed-dose combination separate combination clopidogrel 75mg/aspirin 100mg .</brief_summary>
	<brief_title>Comparative Pharmacokinetics Study Clopidogrel Aspirin Fixed-dose Combination Versus Separate Combination</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>A healthy male volunteer age 20 55 , within 20 % ideal body weight . Have congenital chronic disease medical symptom . Appropriate subject study judging examination ( interview , vital sign , 12lead ECG , physical examination , blood , urinalysis result screening . Able participate entire trial . Signed informed consent form prior study participation . Take metabolic enzyme induce inhibit drug like barbiturate within 28 day prior first IP administration . show evidence acute disease within 28 day prior first IP administration . Have medical history bleed symptom bleed disease Have disease history ( ex . Inflammatory intestinal disease , stomach duodenum ulcer , liver bowel disease , appendectomy except gastrointestinal surgery history ) may influence absorption , distribution , metabolism excretion drug . Have relevant hypersensitivity drug clinically significant allergic disease except mild rhinitis need medication . Have hypersensitivity reaction history Clopidogrel aspirin . Have abnormal laboratory result . AST ALT &gt; 1.25 time upper limit/ Total bilirubin &gt; 1.5 time upper limit/ PT , aPTT , BT upper limit/ Platelet count &lt; 150X10^9/L &gt; 350X10^9/L A drug abuse heavy caffeine consumer ( 5cups per day ) heavy smoker ( 10 cigarette per day ) regular alcohol consumer ( 30g/day ) drinking within 7days prior first IP administration . Have diet ( Especially , grapefruit juicewithin 7days prior first IP administration ) may influence absorption , distribution , metabolism excretion drug ( ) . Have donate whole blood within 60 day prior first IP administration . Participated clinical trial within 90days prior first IP administration . Take medicine affect trial within 10 day prior first IP administration . Appropriate subject trial judging principal investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Combination</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Phase 1</keyword>
</DOC>